LEP, leptin, 3952

N. diseases: 931; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE <b>Conclusions:</b> Overall, we have found that curcumin intake among patients with metabolic syndrome and related disorders was correlated with a significant reduction in BMI, weight, WC, and leptin, and a significant increase in adiponectin levels, but did not affect HR. 31249528 2019
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE Leptin administration to protein-restricted dams inhibits the suppression of 11beta-HSD-2 and may be one mechanism by which the metabolic syndrome is prevented. 15960859 2005
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE Leptin insufficiency in the hypothalamus due to diminished transport of leptin across the blood-brain barrier (BBB) imposed by environmental causes, such as consumption of energy-enriched diets and diminished energy expenditure, orchestrates unregulated fat accrual and the attendant disease cluster of metabolic syndrome. 20478430 2010
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease MGD Leptin-deficient mice are a well characterized model for analysing the metabolic syndrome. 25144618 2014
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE Leptin administration prior to tamoxifen treatment blocks development of the metabolic syndrome without affecting adipocyte loss or regeneration. 28065828 2017
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 AlteredExpression disease BEFREE Leptin levels and homeostatic model assessment (HOMA) scores were significantly higher in SLE MetS<sup>+</sup> than SLE MetS<sup>-</sup> ( p = 0.018; p = 0.04). 29954279 2018
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE Leptin promotes adequate caloric intake and glycemia in healthy lean individuals, harnessing the benefits of the ideal therapy against metabolic syndrome. 30792083 2019
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 GeneticVariation disease BEFREE A 1SD increase in leptin and L/A ratio z-scores or a 1SD decrease in adiponectin z-score were significantly associated with higher risk of MetS. 28511904 2017
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE A concentration of leptin > 52.18 pg/ml (AUC = 0.81, <i>p</i> < 0.0001) and resistin > 4419.27 ng/ml (AUC = 0.67, <i>p</i> = 0.049) had a good predictive value for improvement of the LVEF in the patients without MeS. 28721146 2017
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 AlteredExpression disease BEFREE A Receiver Operator Characteristic curve was used to identify the ability of adiponectin and leptin level to predict the MetS. 31341853 2019
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease MGD Adipocyte size distribution in ob/ob mice during preobese and obese phases of development. 1013161 1976
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE Adipokines such as leptin and adiponectin are thought to be important, but there is new interest in other inflammatory mechanisms related to visceral obesity, insulin resistance, and the metabolic syndrome. 19844182 2010
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE Adiponectin, Leptin and Inflammatory Markers in HIV-associated Metabolic Syndrome in Children and Adolescents. 27832021 2017
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE Adiponectin, leptin and hs-CRP were significantly modified in the group with MetS (p=0.04, p=0.04, p=0.01, respectively). 30530892 2019
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 GeneticVariation disease BEFREE After adjustment, for age and sex, the associations remained significative; LAR was also found to be significantly associated with metabolic syndrome (OR = 1.573, p value =0.000) as well as lower levels of adiponectin (OR = 0.359, p value =0.000) and higher levels of leptin (OR = 1.469, p value =0.001). 28878827 2017
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease MGD Altered insulin signaling in retinal tissue in diabetic states. 15201286 2004
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 AlteredExpression disease BEFREE Although the associations between adiponectin, leptin, resistin and metabolic abnormalities in our paediatric population were similar to those in adults, correlations of FGF21 levels with obesity, IR and MetS were the inverse of those found in adults. 28139438 2017
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE Antipsychotics (APs) are associated with metabolic syndrome, with increases in leptin proposed as an underlying mechanism of AP-induced weight gain. 28980344 2017
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE At baseline, MS was observed in 24 patients, significantly associated with insulin resistance and leptin on multivariate analysis. 30054704 2018
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE CHGA, BMI, and leptin each displayed substantial h(2), and the traits also aggregated with several features of the metabolic syndrome (e.g., insulin resistance, blood pressure (BP), hypertension, catecholamines, and C-reactive protein (CRP)). 21918574 2012
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 GeneticVariation disease BEFREE CRP was significantly associated (P < 0.05) with multiple features of the metabolic syndrome in twins, including body mass index (BMI), blood pressure (BP), leptin and lipids. 17211240 2007
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease BEFREE Disturbances in leptin and insulin signaling pathways are related to obesity and metabolic syndrome (MS) with increased risk of diabetes and cardiovascular disease. 22185674 2011
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease MGD Dysregulation of the Hypothalamus-Pituitary-Adrenal Axis in Male and Female, Genetically Obese (ob/ob) Mice. 21554665 1992
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 Biomarker disease MGD Enhanced sensitivity of pancreatic islets from preobese 2-week-old ob/ob mice to neurohormonal stimulation of insulin secretion. 7835283 1995
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.600 AlteredExpression disease BEFREE Evaluation of adiponectin and leptin levels and oxidative stress in bipolar disorder patients with metabolic syndrome treated by valproic acid. 28875764 2017